Claudia G. Santi

Sao Paulo, SP, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Refractory linear IgA dermatosis in childhood: a successful response to rituximab.

Refractory linear IgA dermatosis in childhood: a successful response to rituximab.

Journal: Anais brasileiros de dermatologia

Published: August 06, 2025

Comparative analysis of the prevalence of histopathological findings between DRESS syndrome (drug rash with eosinophilia and systemic symptoms) and drug-induced maculopapular rash: a cross-sectional study.

Comparative analysis of the prevalence of histopathological findings between DRESS syndrome (drug rash with eosinophilia and systemic symptoms) and drug-induced maculopapular rash: a cross-sectional study.

Journal: Anais brasileiros de dermatologia

Published: April 29, 2025

Bullous pemphigoid: epidemiological, clinical, and therapeutic analysis of 189 patients in a tertiary center in Brazil.

Bullous pemphigoid: epidemiological, clinical, and therapeutic analysis of 189 patients in a tertiary center in Brazil.

Journal: Anais brasileiros de dermatologia

Published: August 12, 2024

Vulvar ulcers secondary to aortic angiosarcoma in a patient with misdiagnosed cancer of unknown primary origin⋆.

Vulvar ulcers secondary to aortic angiosarcoma in a patient with misdiagnosed cancer of unknown primary origin⋆.

Journal: Anais brasileiros de dermatologia

Published: June 07, 2024

Pyoderma gangrenosum: a 22-year follow-up of patients in a tertiary reference hospital in Brazil.

Pyoderma gangrenosum: a 22-year follow-up of patients in a tertiary reference hospital in Brazil.

Journal: Anais brasileiros de dermatologia

Published: April 28, 2024

Increased expression of in situ CD123 and reduced Toll-like receptor 7/9 signalling pathway suggest impaired activation of plasmacytoid dendritic cells in recurrent erythema multiforme.

Increased expression of in situ CD123 and reduced Toll-like receptor 7/9 signalling pathway suggest impaired activation of plasmacytoid dendritic cells in recurrent erythema multiforme.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: December 11, 2023

Persistence of IgG4 as a potential serological marker of disease activity in patients with epidermolysis bullosa acquisita treated with rituximab.

Persistence of IgG4 as a potential serological marker of disease activity in patients with epidermolysis bullosa acquisita treated with rituximab.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: April 16, 2023

Considerations on Immunization and Immunosuppression of Patients With Autoimmune Blistering Diseases During COVID-19 Pandemic in Brazil: Case Report.

Considerations on Immunization and Immunosuppression of Patients With Autoimmune Blistering Diseases During COVID-19 Pandemic in Brazil: Case Report.

Journal: Frontiers in medicine

Published: November 09, 2021

Epidermolysis bullosa acquisita.

Epidermolysis bullosa acquisita.

Journal: Anais brasileiros de dermatologia

Published: April 13, 2021

Recurrent erythema multiforme: A therapeutic proposal for a chronic disease.

Recurrent erythema multiforme: A therapeutic proposal for a chronic disease.

Journal: The Journal of dermatology

Published: January 13, 2021

Systemic retinoid treatment in a case of hyperkeratotic lichenoid paraneoplastic pemphigus.

Systemic retinoid treatment in a case of hyperkeratotic lichenoid paraneoplastic pemphigus.

Journal: International journal of dermatology

Published: December 30, 2020

Autoimmune bullous diseases in pregnancy: clinical and epidemiological characteristics and therapeutic approach.

Autoimmune bullous diseases in pregnancy: clinical and epidemiological characteristics and therapeutic approach.

Journal: Anais brasileiros de dermatologia

Published: July 10, 2020

Showing 1-12 of 32

Last Updated: 09/26/2026